Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)

Neurocrine Clinical Site, Brussels

Neurocrine Clinical Site, Ghent

Neurocrine Clinical Site, New York

Neurocrine Clinical Site, New Hyde Park

Neurocrine Clinical Site, Athens

Neurocrine Clinical Site, Berlin

Neurocrine Clinical Site, Pittsburgh

Neurocrine Clinical Site, Philadelphia

Neurocrine Clinical Site, Washington D.C.

Neurocrine Clinical Site, Milan

Neurocrine Clinical Site, Atlanta

Neurocrine Clinical Site, Bordeau

Neurocrine Clinical Site, Birmingham

Neurocrine Clinical Site, Magdeburg

Neurocrine Clinical Site, Bologna

Neurocrine Clinical Site, Seville

Neurocrine Clinical Site, Indianapolis

Neurocrine Clinical Site, Ann Arbor

Neurocrine Clinical Site, Angers

Neurocrine Clinical Site, Minneapolis

Neurocrine Clinical site, St Louis

Neurocrine Clinical Site, Heidelberg

Neurocrine Clinical Site, Oklahoma City

Neurocrine Clinical Site, Tulsa

Neurocrine Clinical Site, Paris

Neurocrine Clinical Site, Paris

Neurocrine Clinical Site, Dallas

Neurocrine Clinical Site, Aurora

Neurocrine Clinical Site, Napoli

Neurocrine Clinical Site, Los Angeles

Neurocrine Clinical Site, San Diego

Neurocrine Clinical Site, Orange

Neurocrine Clinical Site, San Francisco

Neurocrine Clinical Site, Le Kremlin-Bicêtre

Neurocrine Clinical Site, Seattle

Neurocrine Clinical Site, Hartford

Neurocrine Clinical Site, Boston

Neurocrine Clinical Site, Edmonton

Neurocrine Clinical Site, Vancouver

Neurocrine Clinical Site, Montreal

Neurocrine Clinical Site, Athens

Neurocrine Clinical Site, Roma

Neurocrine Clinical Site, Gdansk

Neurocrine Clinical Site, Rzeszów

Neurocrine Clinical Site, Barcelona

Neurocrine Clinical Site, London